Research

SUBSCRIBE TO OUR NEWSLETTER

October 2022

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

February 2022

Models of Psychedelic Drug Action: Modulation of Cortical-Subcortical Circuits

September 2021

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

October 2017

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Our Mission

The Psychedelic Medicine Coalition (PMC) is a DC-based, multi-industry 501(C)6 organization with the mission to improve the commercial and regulatory space for novel and alternative treatments to mental health affiliations.

Get in Touch